デフォルト表紙
市場調査レポート
商品コード
1702930

ビリルビン血液検査の世界市場レポート 2025年

Bilirubin Blood Test Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
ビリルビン血液検査の世界市場レポート 2025年
出版日: 2025年04月01日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ビリルビン血液検査市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.5%で19億6,000万米ドルに成長します。予測期間の成長は、早期診断の需要拡大、診断ラボの拡大、慢性疾患の罹患率上昇、新興市場の成長、高度分析の統合、研究資金の増加などに起因します。予測期間の主な動向には、非侵襲的検査法の開発、デジタルヘルスソリューションとの統合、家庭用検査キットの進歩、検査精度とスピードの向上、個別化医療アプローチ、スマート診断機器、携帯機器の開発などがあります。

肝疾患の有病率の増加がビリルビン血液検査市場の成長を牽引すると予測されます。肝疾患には、肝臓の機能を効果的に低下させるさまざまな病態が含まれ、多くの場合、感染症、過度のアルコール摂取、代謝異常などの要因が原因となります。肝疾患患者の増加は、肥満率の増加、アルコール摂取量の多さ、ウイルス感染、不健康なライフスタイルの選択に関連しており、これらはすべて肝臓の損傷や機能障害の原因となっています。肝疾患は体内のビリルビン濃度を著しく変化させるため、ビリルビン血液検査は肝機能の診断とモニタリングに不可欠です。これらの検査は、患者の健康状態に関する貴重な洞察を提供し、ヘルスケアプロバイダーが肝臓関連疾患を管理する際のサポートとなります。例えば、欧州疾病予防管理センターが2024年4月に報告したところによると、EU/EEA加盟30カ国における2022年のB型肝炎ウイルス(HBV)感染症例数は28,855例で、2021年の16,187例から78%増加しました。2022年の感染者数は、人口10万人当たり8.5人でした。このような肝臓疾患の罹患率の増加は、ビリルビン血液検査市場を押し上げると予想されます。

ビリルビン血液検査市場の主要企業は、戦略的パートナーシップを結ぶことで、市場参入の幅を広げ、製品ラインナップの充実を図っています。戦略的パートナーシップとは、リソースや専門知識を組み合わせて相互の目標を達成する組織間の協力関係を指します。例えば、2023年12月、イスラエルを拠点とする医療診断用バイオテクノロジー企業であるCalmark Sweden ABは、サウジアラビアのTechno Orbitsと新生児用ビリルビン検査の独占販売代理店契約を締結しました。テクノオービッツ社は、保健省を含む確立されたネットワークとコネクションを活用し、カルマーク社製品の流通と販売を管理します。このパートナーシップは、サウジアラビア市場へのカルマーク社のビリルビン検査の導入を促進することを目的としており、規制当局への登録には3ヶ月から6ヶ月を要する見込みです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界ビリルビン血液検査PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界のビリルビン血液検査市場:成長率分析
  • 世界のビリルビン血液検査市場の実績:規模と成長, 2019-2024
  • 世界のビリルビン血液検査市場の予測:規模と成長, 2024-2029, 2034F
  • 世界ビリルビン血液検査総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界のビリルビン血液検査市場テストの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 総血清ビリルビン検査
  • 間接ビリルビン検査または非抱合型ビリルビン検査
  • 直接ビリルビン検査または抱合ビリルビン検査
  • 世界のビリルビン血液検査市場:年齢層別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 大人
  • 小児科
  • 乳児
  • 世界のビリルビン血液検査市場:用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院
  • クリニック
  • その他の用途
  • 世界のビリルビン血液検査市場総血清ビリルビン検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 定期検査
  • 肝機能評価
  • 新生児黄疸検出
  • 世界のビリルビン血液検査市場間接ビリルビン検査または非抱合型ビリルビン検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 溶血性貧血の診断
  • ギルバート症候群の検出
  • 肝疾患のモニタリング
  • 世界のビリルビン血液検査市場、直接ビリルビン検査または抱合ビリルビン検査の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 胆管閉塞の診断
  • 肝炎および肝疾患モニタリング
  • 肝機能評価後

第7章 地域別・国別分析

  • 世界のビリルビン血液検査市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界のビリルビン血液検査市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ビリルビン血液検査市場:競合情勢
  • ビリルビン血液検査市場:企業プロファイル
    • F.Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Koninklijke Philips N.V.
  • Mindray Medical International Limited
  • Beckman Coulter Inc.
  • Dragerwerk AG and Co. KGaA
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Konica Minolta Inc.
  • Instrumentation Laboratory LLC
  • Randox Laboratories Ltd.
  • Ortho Clinical Diagnostics Inc.
  • Natus Medical Incorporated
  • Nova Biomedical
  • Advanced Instruments LLC
  • Helmer Scientific Inc.
  • Reichert Technologies Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • ビリルビン血液検査市場2029:新たな機会を提供する国
  • ビリルビン血液検査市場2029:新たな機会を提供するセグメント
  • ビリルビン血液検査市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r29586

The bilirubin blood test is a diagnostic procedure used to measure bilirubin levels in the blood. This test is important for evaluating liver function and diagnosing conditions such as jaundice and liver disease. It is crucial for assessing bilirubin metabolism and identifying liver health issues.

The main types of bilirubin blood tests includes the total serum bilirubin test, the indirect or unconjugated bilirubin test, and the direct or conjugated bilirubin test. The total serum bilirubin test measures the combined amount of unconjugated (indirect) and conjugated (direct) bilirubin in the blood. This test is essential for assessing overall liver health and diagnosing various liver-related conditions. The test is applicable to adults, pediatrics, and infants, and it is used in hospitals, clinics, and other healthcare settings.

The bilirubin blood test market research report is one of a series of new reports from the business research company that provides bilirubin blood test market statistics, including bilirubin blood test industry global market size, regional shares, competitors with an bilirubin blood test market share, detailed bilirubin blood test market segments, market trends and opportunities, and any further data you may need to thrive in the bilirubin blood test industry. This bilirubin blood test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bilirubin blood test market size has grown strongly in recent years. It will grow from $1.37 billion in 2024 to $1.47 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to the increasing prevalence of liver diseases, growth in neonatal care, technological advancements, rising health awareness, healthcare infrastructure development, regulatory approvals and guidelines, and increased adoption of point-of-care testing.

The bilirubin blood test market size is expected to see strong growth in the next few years. It will grow to $1.96 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to growing demand for early diagnosis, expansion of diagnostic laboratories, rising incidence of chronic diseases, emerging markets growth, integration of advanced analytics, increased research funding. Major trends in the forecast period include development of non-invasive testing methods, integration with digital health solutions, advances in home testing kits, enhanced test accuracy and speed, personalized medicine approaches, smart diagnostic devices, development of portable devices.

The increasing prevalence of liver diseases is anticipated to drive the growth of the bilirubin blood test market. Liver diseases encompass a variety of conditions that impair the liver's ability to function effectively, often due to factors such as infections, excessive alcohol consumption, or metabolic disorders. The rise in liver disease cases is linked to escalating obesity rates, high alcohol intake, viral infections, and unhealthy lifestyle choices, all of which contribute to liver damage and dysfunction. Since liver disease can significantly alter bilirubin levels in the body, bilirubin blood tests are essential for diagnosing and monitoring liver function. These tests provide valuable insights into patient health and support healthcare providers in managing liver-related conditions. For example, the European Centre for Disease Prevention and Control reported in April 2024 that there were 28,855 cases of hepatitis B virus (HBV) infection across 30 EU/EEA Member States in 2022, marking a 78% increase from 16,187 cases in 2021. The 2022 cases amounted to a crude rate of 8.5 cases per 100,000 people. This rising incidence of liver diseases is expected to boost the bilirubin blood test market.

Leading companies in the bilirubin blood test market are increasingly forming strategic partnerships to broaden their reach and improve their offerings. A strategic partnership involves a collaborative relationship between organizations that combines resources and expertise to achieve mutual goals. For example, in December 2023, Calmark Sweden AB, an Israel-based medical diagnostic biotechnology firm, entered into an exclusive distributor agreement with Techno Orbits in Saudi Arabia for its bilirubin test for newborns. Techno Orbits will manage the distribution and sales of Calmark's product, utilizing its established network and connections, including with the Ministry of Health. This partnership aims to facilitate the introduction of Calmark's bilirubin test into the Saudi market, with regulatory registration expected to take between 3 to 6 months.

In December 2023, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a China-based medical technology provider, acquired a 75% stake in DiaSys Diagnostic Systems GmbH for an undisclosed sum. This acquisition is designed to bolster Mindray's competitive position in the in vitro diagnostic (IVD) sector by leveraging DiaSys's established supply chains and expertise in clinical chemistry. The acquisition is expected to enhance Mindray's capabilities in serving medium- to large-volume customers and improve service delivery. DiaSys Diagnostic Systems GmbH, based in Germany, specializes in diagnostic systems, including bilirubin blood tests for liver diseases.

Major companies operating in the bilirubin blood test market are F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., Mindray Medical International Limited, Beckman Coulter Inc., Dragerwerk AG and Co. KGaA, Sysmex Corporation, Bio-Rad Laboratories Inc., Konica Minolta Inc., Instrumentation Laboratory LLC, Randox Laboratories Ltd., Ortho Clinical Diagnostics Inc., Natus Medical Incorporated, Nova Biomedical, Advanced Instruments LLC, Helmer Scientific Inc., Reichert Technologies Inc., Rousselet Robatel SAS, Labnet International Inc., AVI Healthcare Pvt. Ltd., Ginevri S.p.A.

North America was the largest region in the bilirubin blood test market in 2024. The regions covered in the bilirubin blood test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bilirubin blood test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bilirubin blood test market consists of sales of products such as diagnostic devices for measuring bilirubin levels, including test kits, blood analyzers, and automated testing systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bilirubin Blood Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bilirubin blood test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bilirubin blood test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bilirubin blood test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Total Serum Bilirubin Test; Indirect Or Unconjugated Bilirubin Test; Direct Or Conjugated Bilirubin Test
  • 2) By Age Group: Adults; Pediatrics; Infants
  • 3) By Application: Hospital; Clinic; Other Applications
  • Subsegments:
  • 1) By Total Serum Bilirubin Test: Routine Screening; Liver Function Assessment; Newborn Jaundice Detection
  • 2) By Indirect Or Unconjugated Bilirubin Test: Hemolytic Anemia Diagnosis; Gilbert's Syndrome Detection; Monitoring For Preliver Conditions
  • 3) By Direct Or Conjugated Bilirubin Test: Bile Duct Obstruction Diagnosis; Hepatitis And Liver Disease Monitoring; Post-Liver Condition Assessment
  • Companies Mentioned: F.Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bilirubin Blood Test Market Characteristics

3. Bilirubin Blood Test Market Trends And Strategies

4. Bilirubin Blood Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Bilirubin Blood Test Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Bilirubin Blood Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Bilirubin Blood Test Market Growth Rate Analysis
  • 5.4. Global Bilirubin Blood Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Bilirubin Blood Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Bilirubin Blood Test Total Addressable Market (TAM)

6. Bilirubin Blood Test Market Segmentation

  • 6.1. Global Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Total Serum Bilirubin Test
  • Indirect Or Unconjugated Bilirubin Test
  • Direct Or Conjugated Bilirubin Test
  • 6.2. Global Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adults
  • Pediatrics
  • Infants
  • 6.3. Global Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Clinic
  • Other Applications
  • 6.4. Global Bilirubin Blood Test Market, Sub-Segmentation Of Total Serum Bilirubin Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Routine Screening
  • Liver Function Assessment
  • Newborn Jaundice Detection
  • 6.5. Global Bilirubin Blood Test Market, Sub-Segmentation Of Indirect Or Unconjugated Bilirubin Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hemolytic Anemia Diagnosis
  • Gilbert's Syndrome Detection
  • Monitoring For Preliver Conditions
  • 6.6. Global Bilirubin Blood Test Market, Sub-Segmentation Of Direct Or Conjugated Bilirubin Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bile Duct Obstruction Diagnosis
  • Hepatitis And Liver Disease Monitoring
  • Post-Liver Condition Assessment

7. Bilirubin Blood Test Market Regional And Country Analysis

  • 7.1. Global Bilirubin Blood Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Bilirubin Blood Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bilirubin Blood Test Market

  • 8.1. Asia-Pacific Bilirubin Blood Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bilirubin Blood Test Market

  • 9.1. China Bilirubin Blood Test Market Overview
  • 9.2. China Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bilirubin Blood Test Market

  • 10.1. India Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bilirubin Blood Test Market

  • 11.1. Japan Bilirubin Blood Test Market Overview
  • 11.2. Japan Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bilirubin Blood Test Market

  • 12.1. Australia Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bilirubin Blood Test Market

  • 13.1. Indonesia Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bilirubin Blood Test Market

  • 14.1. South Korea Bilirubin Blood Test Market Overview
  • 14.2. South Korea Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bilirubin Blood Test Market

  • 15.1. Western Europe Bilirubin Blood Test Market Overview
  • 15.2. Western Europe Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bilirubin Blood Test Market

  • 16.1. UK Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bilirubin Blood Test Market

  • 17.1. Germany Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bilirubin Blood Test Market

  • 18.1. France Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bilirubin Blood Test Market

  • 19.1. Italy Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bilirubin Blood Test Market

  • 20.1. Spain Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bilirubin Blood Test Market

  • 21.1. Eastern Europe Bilirubin Blood Test Market Overview
  • 21.2. Eastern Europe Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bilirubin Blood Test Market

  • 22.1. Russia Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bilirubin Blood Test Market

  • 23.1. North America Bilirubin Blood Test Market Overview
  • 23.2. North America Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bilirubin Blood Test Market

  • 24.1. USA Bilirubin Blood Test Market Overview
  • 24.2. USA Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bilirubin Blood Test Market

  • 25.1. Canada Bilirubin Blood Test Market Overview
  • 25.2. Canada Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bilirubin Blood Test Market

  • 26.1. South America Bilirubin Blood Test Market Overview
  • 26.2. South America Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bilirubin Blood Test Market

  • 27.1. Brazil Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bilirubin Blood Test Market

  • 28.1. Middle East Bilirubin Blood Test Market Overview
  • 28.2. Middle East Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bilirubin Blood Test Market

  • 29.1. Africa Bilirubin Blood Test Market Overview
  • 29.2. Africa Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bilirubin Blood Test Market Competitive Landscape And Company Profiles

  • 30.1. Bilirubin Blood Test Market Competitive Landscape
  • 30.2. Bilirubin Blood Test Market Company Profiles
    • 30.2.1. F.Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Bilirubin Blood Test Market Other Major And Innovative Companies

  • 31.1. Koninklijke Philips N.V.
  • 31.2. Mindray Medical International Limited
  • 31.3. Beckman Coulter Inc.
  • 31.4. Dragerwerk AG and Co. KGaA
  • 31.5. Sysmex Corporation
  • 31.6. Bio-Rad Laboratories Inc.
  • 31.7. Konica Minolta Inc.
  • 31.8. Instrumentation Laboratory LLC
  • 31.9. Randox Laboratories Ltd.
  • 31.10. Ortho Clinical Diagnostics Inc.
  • 31.11. Natus Medical Incorporated
  • 31.12. Nova Biomedical
  • 31.13. Advanced Instruments LLC
  • 31.14. Helmer Scientific Inc.
  • 31.15. Reichert Technologies Inc.

32. Global Bilirubin Blood Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bilirubin Blood Test Market

34. Recent Developments In The Bilirubin Blood Test Market

35. Bilirubin Blood Test Market High Potential Countries, Segments and Strategies

  • 35.1 Bilirubin Blood Test Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Bilirubin Blood Test Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Bilirubin Blood Test Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer